benzyloxycarbonyl-phe-ala-fluormethylketone has been researched along with Trypanosomiasis, African in 1 studies
*Trypanosomiasis, African: A disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the TSETSE FLY. Involvement of the central nervous system produces African sleeping sickness. Nagana is a rapidly fatal trypanosomiasis of horses and other animals. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelo, IC; Conti, P; De Micheli, C; Ettari, R; Micale, N; Pinto, A; Tamborini, L | 1 |
1 other study(ies) available for benzyloxycarbonyl-phe-ala-fluormethylketone and Trypanosomiasis, African
| Article | Year |
|---|---|
Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis.
Topics: Cathepsin L; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Protozoan Proteins; Structure-Activity Relationship; Trypanocidal Agents; Trypanosomiasis, African | 2013 |